Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1Phase 2/3 1Phase 2 1Phase 1 1

Status

Completed 11Terminated 4Recruiting 3Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Chondrosarcoma 1

Interventions

pembrolizumab 85Cyclophosphamide 74Nivolumab 58fludarabine 49Specimen Handling 49Magnetic Resonance Spectroscopy 43Carboplatin 41Biopsy 39Radiotherapy 32fludarabine phosphate 30atezolizumab 27Gemcitabine 27Paclitaxel 26Ipilimumab 26Cisplatin 24venetoclax 23Radiation 23Dexamethasone 22Radiosurgery 21durvalumab 20Rituximab 20Temozolomide 18Lenalidomide 18Bevacizumab 17palbociclib 15Pemetrexed 15Decitabine 15Cytarabine 15130-nm albumin-bound paclitaxel 15Oxaliplatin 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Active not recruiting × Zoledronic Acid × Clear all
NCT03173976 2025-11-06

Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial

University of Iowa

Phase 1 Active not recruiting
17 enrolled
Sarcoma

Chondrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡